However, it doesn't necessarily indicate that ocular rosacea always accompanies its skin counterpart. It can surface independently, too. In the case of ocular rosacea, inflammation can affect ...

Patients with rosacea and skin of color are more likely to have severe disease phenotypes when compared with White patients with rosacea.

Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...

Phymatous rosacea: The skin thickens and becomes bumpy, particularly on the nose, which may cause it to enlarge. Ocular rosacea: The eyes and eyelids sting and become inflamed, watery, and bloodshot.

IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27 th Annual Global ...

Tarsus Pharmaceuticals Inc (NASDAQ:TARS) is advancing its pipeline with a phase 2 trial for ocular rosacea and a Lyme disease prevention program, indicating strong future growth potential.